DHL Group to invest $575m in healthcare, logistics expansion across Africa, Middle East

DHL Group, the global logistics giant, has today a €500 million ($575 million) investment to expand its healthcare logistics network across Africa and the Middle East over the next five years.

The initiative aims to capitalise on China’s growing influence in these regions by enhancing the delivery of time-critical medical supplies, including vaccines, stem cells, and cryogenic products.

This strategic move underscores the company’s commitment to strengthening global supply chains amid rising demand for healthcare services, though challenges such as infrastructure gaps and regulatory complexities loom large.

The investment targets key growth markets, with a particular emphasis on Africa, where DHL sees untapped potential. Annette Naude, head of healthcare for Europe, the Middle East, and Africa (EMEA), highlighted the focus on time-sensitive shipments critical to public health.

The plan includes expanding cold chain infrastructure, upgrading existing facilities, and establishing new logistics hubs to support the distribution of temperature-sensitive pharmaceuticals. 

The group’s expansion spans its four divisions: DHL Express, DHL Global Forwarding, DHL Supply Chain, and DHL eCommerce, enhancing its ability to handle complex healthcare logistics.

In the Middle East, the company aims to bolster its role as a trade gateway connecting Asia, Europe, and Africa, with John Pearson, CEO of DHL Express, noting the region’s emergence as a global logistics hub.

The investment, set to unfold between 2024 and 2030, will expand networks and capacities, supporting local businesses and multinational companies expanding into these markets.

DHL expansions: economic and healthcare context 

The announcement comes as Africa and the Middle East face increasing health-care demands, exacerbated by population growth and limited infrastructure. The World Health Organisation (WHO) reported in 2024 that only 30% of African countries have adequate cold chain systems for vaccines, a gap the company seeks to address. 

China’s push into the region, including infrastructure projects under the Belt and Road Initiative, has spurred demand for reliable logistics, with DHL positioning itself to meet this need. In Egypt, where DHL Express already leads in logistics, the company supports pharmaceutical giants like Eva Pharma, signalling a foundation for further growth.

The Middle East, particularly the Gulf Cooperation Council (GCC) countries, is witnessing a healthcare boom, with Saudi Arabia’s Vision 2030 and the UAE’s health sector investments driving demand.

DHL’s focus on e-commerce growth, fuelled by local entrepreneurs, aligns with this trend, as Pearson emphasised the export potential for smaller companies. The investment also responds to global supply chain disruptions, with Amadou Diallo, CEO of DHL Global Forwarding for the Middle East and Africa, reaffirming confidence in the region’s economic development amid volatility.

Operational details and partnerships

It plans to enhance its fleet with specialised vehicles and deploy advanced tracking technologies to ensure the integrity of medical shipments. The company will collaborate with local governments and health organisations to navigate regulatory frameworks, a critical factor given Africa’s diverse trade policies.

In Nigeria, where healthcare logistics face challenges from poor infrastructure, DHL’s expansion could support initiatives like the National Primary Health Care Development Agency’s vaccine distribution, though analysts caution that last-mile delivery remains a hurdle.

The initiative builds on DHL’s existing footprint, with over 350,000 employees across 220 countries and territories. In Egypt, Ahmed Elfangary, country manager of DHL Express, has positioned the company as a government partner, a model likely to expand regionally. The investment will also leverage digital innovation, including sustainable transport solutions, to strengthen resilient supply chains, a priority amid global uncertainties.

Despite the optimism, the company faces significant challenges. Africa’s fragmented logistics landscape, marked by inadequate roads and customs delays, could slow implementation. Regulatory compliance, especially in healthcare, requires navigating stringent standards, while competition from local players and rivals like FedEx intensifies. 

Opportunities abound, however. The Middle East’s role as a trade conduit and Africa’s rising pharmaceutical market, valued at $20 billion in 2024 by Statista, offer substantial growth potential. DHL’s focus on stem cells and cryogenics taps into cutting-edge medical needs, positioning it as a leader in specialised logistics.